[
  {
    "ts": null,
    "headline": "Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More",
    "summary": "The report highlights opportunities in strategic investment and optimizing trial locations. It identifies key clinical trial trends and successes globally, aiding competitive positioning and efficient allocation of resources in the global therapeutics market.Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The \"Intracranial Hemorrhage - Global Clinical Trials Review, 2025\" has been added to ResearchAndMarkets.com's offering. The report offers a comprehensive overview of the global clinical trials lands",
    "url": "https://finnhub.io/api/news?id=73892cb07a90c61e243a34982a4d468fe4894d36f87fabfc48cdc0640aeeea0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756223880,
      "headline": "Intracranial Hemorrhage Clinical Trials Review 2025 Featuring Idorsia, Edge Therapeutics, Grace Therapeutics, Johnson & Johnson, AstraZeneca, NeurOp and More",
      "id": 136526722,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The report highlights opportunities in strategic investment and optimizing trial locations. It identifies key clinical trial trends and successes globally, aiding competitive positioning and efficient allocation of resources in the global therapeutics market.Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The \"Intracranial Hemorrhage - Global Clinical Trials Review, 2025\" has been added to ResearchAndMarkets.com's offering. The report offers a comprehensive overview of the global clinical trials lands",
      "url": "https://finnhub.io/api/news?id=73892cb07a90c61e243a34982a4d468fe4894d36f87fabfc48cdc0640aeeea0c"
    }
  },
  {
    "ts": null,
    "headline": "2 High-Conviction Picks For 7.73% Growth And 4.22% Yield Within A Dividend Portfolio",
    "summary": "Through DPSTF and META, we increased Dividend Income Accelerator Portfolio's sector diversification and global exposure. Learn more about the portfolio here.",
    "url": "https://finnhub.io/api/news?id=3452d5cd9b4cf8d4251a0ea48074df10fe22dad78a44764ff71b7843f2de36f2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756220400,
      "headline": "2 High-Conviction Picks For 7.73% Growth And 4.22% Yield Within A Dividend Portfolio",
      "id": 136529227,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2188450078/image_2188450078.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Through DPSTF and META, we increased Dividend Income Accelerator Portfolio's sector diversification and global exposure. Learn more about the portfolio here.",
      "url": "https://finnhub.io/api/news?id=3452d5cd9b4cf8d4251a0ea48074df10fe22dad78a44764ff71b7843f2de36f2"
    }
  },
  {
    "ts": null,
    "headline": "ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression",
    "summary": "AbbVie is acquiring Gilgamesh's lead psychedelic drug bretisilocin for up to $1.2B, aiming to expand its depression treatment pipeline",
    "url": "https://finnhub.io/api/news?id=fa42595c1177faf797db732ed7f6e1b1b7467bbf223251dfe67cc5f10483f65a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756210080,
      "headline": "ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression",
      "id": 136525164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "AbbVie is acquiring Gilgamesh's lead psychedelic drug bretisilocin for up to $1.2B, aiming to expand its depression treatment pipeline",
      "url": "https://finnhub.io/api/news?id=fa42595c1177faf797db732ed7f6e1b1b7467bbf223251dfe67cc5f10483f65a"
    }
  },
  {
    "ts": null,
    "headline": "Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference",
    "summary": "SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 9, 2025, at 4:05 p.m. ET. The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of Leg",
    "url": "https://finnhub.io/api/news?id=7ccbd40f72e80b24e503e3f5f7295e0a289f6cd35d6966c8b619df6f6e86f452",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756209600,
      "headline": "Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference",
      "id": 136525646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York, NY on Tuesday, September 9, 2025, at 4:05 p.m. ET. The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of Leg",
      "url": "https://finnhub.io/api/news?id=7ccbd40f72e80b24e503e3f5f7295e0a289f6cd35d6966c8b619df6f6e86f452"
    }
  },
  {
    "ts": null,
    "headline": "J&J earmarks $2B for Fujifilm’s North Carolina facility",
    "summary": "The 10-year deal will expand the biopharma giant’s capacity to better meet U.S. demand for advanced medicines and create 120 jobs for the Raleigh area.",
    "url": "https://finnhub.io/api/news?id=05b5abc2be75b243b5612af3a06f9a3b2a84e6172eb4c56cd993b8643484b686",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756209240,
      "headline": "J&J earmarks $2B for Fujifilm’s North Carolina facility",
      "id": 136530085,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The 10-year deal will expand the biopharma giant’s capacity to better meet U.S. demand for advanced medicines and create 120 jobs for the Raleigh area.",
      "url": "https://finnhub.io/api/news?id=05b5abc2be75b243b5612af3a06f9a3b2a84e6172eb4c56cd993b8643484b686"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson to Invest $2 Billion in New North Carolina Facility",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Stocks for 5 Years (Long-Term Stock Portfolio). On August 21, Johnson & Johnson (NYSE:JNJ) announced that it will be expanding its presence in North Carolina through a manufacturing facility of more than 160,000 square feet at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, North […]",
    "url": "https://finnhub.io/api/news?id=8b185c8a6d103e3e86b06d7f269a94c8c9cc36ecd61e169bcb9b4d859dec6675",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756180551,
      "headline": "Johnson & Johnson to Invest $2 Billion in New North Carolina Facility",
      "id": 136523892,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 Best Stocks for 5 Years (Long-Term Stock Portfolio). On August 21, Johnson & Johnson (NYSE:JNJ) announced that it will be expanding its presence in North Carolina through a manufacturing facility of more than 160,000 square feet at FUJIFILM’s new biopharmaceutical manufacturing site in Holly Springs, North […]",
      "url": "https://finnhub.io/api/news?id=8b185c8a6d103e3e86b06d7f269a94c8c9cc36ecd61e169bcb9b4d859dec6675"
    }
  }
]